Overview of Dr. Guan
Jian Guan, MD, based in Houston, TX, specializes in Internal Medicine with subspecialties in Hematology and Oncology. He completed his residency in Internal Medicine at AdventHealth Florida and a fellowship in Hematology and Medical Oncology at Houston Methodist Hospital. Dr. Guan holds a PhD in Molecular Medicine from Boston University and graduated from Tongji Medical University in 2002. He is currently a Medical Oncologist specialized in GI oncology at Houston Methodist Hospital Neal Cancer Center. Dr. Guan has led several clinical trials.
Education & Training
Methodist Hospital (Houston)Fellowship, Hematology and Medical Oncology, 2021 - 2024
AdventHealth Florida (Orlando)Residency, Internal Medicine, 2015 - 2018
Boston University School of MedicinePhD, Molecular Medicine , 2006 - 2012
Tongji Medical UniversityClass of 2002
Certifications & Licensure
TX State Medical License 2021 - 2027
FL State Medical License 2015 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Fellow Houston Methodist Hospital, Hematology/Oncology Fellowship, 2023
- Research Mentor Award Adventhealth Orlando Graduate Medical Education, 2021
- First place in Academic Debate American Liver Foundation (Southeastern Division), 2019
- Join now to see all
Clinical Trials
- Durvalumab with Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer Start of enrollment: 2020 Mar 03
- SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC Start of enrollment: 2017 Jul 01
- Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy Start of enrollment: 2021 Oct 14
Publications & Presentations
PubMed
- 7 citationsNeighborhood Walkability Is Associated With Lower Burden of Cardiovascular Risk Factors Among Cancer Patients.Nwabunie Nwana, Omar Mohamed Makram, Juan C Nicolas, Alan Pan, Rakesh Gullapelli
JACC. Cardiooncology. 2024-06-01 - 12 citationsA Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.Jian Guan, Kai Sun, Carlo A Guerrero, Junjun Zheng, Yitian Xu
International Journal of Radiation Oncology, Biology, Physics. 2024-04-01 - 10 citationsA Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors.Mengni Guo, Jieying Liu, Ruoyu Miao, Zohaib Ahmed, James Yu
Journal of Immunotherapy. 2022-09-05
Press Mentions
Interaction Between Obstructive Sleep Apnea and Short Sleep Duration on Insulin Resistance: A Large-Scale StudyJune 16th, 2020
Professional Memberships
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
